Mycobacteriosis in companion psittacine birds: A review

Journal of Avian Medicine and Surgery

Volumn 21, Issue 3, 2007, Pages 181-187

  Lennox, Angela M ^a  

^a Avian and Exotic Animal Clinic of Indianapolis   (United States)

Author keywords

Avian; Mycobacteriosis; Mycobacterium avium; Mycobacterium genevense; Psittacine birds; Zoonosis

Indexed keywords

AVES; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; PSITTACIFORMES;

EID: 37649013182     PISSN: 10826742     EISSN: None     Source Type: Journal    
DOI: 10.1647/1082-6742(2007)21[181:MICPBA]2.0.CO;2     Document Type: Review

References (40)

1. Tell LA, Woods L, Cromie RL. Mycobacteriosis in birds. Rev Sci Tech Off Int Epiz. 2001;20:180-203.
2. VanDerHeyden N. Clinical manifestations of mycobacteriosis in pet birds. Sem Avian Exotic Pet Med. 1997;6:18-24.
3. Hoop R. Public health implications of exotic pet mycobacteriosis. Sem Avian Exotic Pet Med. 1997;6:3-8.
4. Mendenhall MK, Ford SL, Emerson CL, et al. Brief communications: detection and differentiation of Mycobacterium avium and Mycobacterium genavense by polymerase chain reaction and restriction enzyme digestion analysis. J Vet Diagn Invest. 2000;2:57-60.
5. Hoop R. Etiological agents of mycobacterioses in pet birds between 1986 and 1995. J Clinical Microbiol. 1996;34:991-992.
6. Washko RM, Hoefer H, Kiehn TE, et al. Mycobacterium tuberculosis infection in a green-winged macaw (Ara chloroptera): report with public health implications. J Clin Microbiol. 1998;36: 1101-1102.
7. Phalen DN. Avian mycobacteriosis. In: Bonagura FD, ed. Kirk's Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:1116-1118.
8. Kock ND, Kock RA, Wambua J, et al. Mycobacterium avium related epizootic in free-ranging lesser flamingos in Kenya. J Wild Dis. 1999;35: 297-300.
9. VanDerHeyden N. Mycobacteriosis. In: Rosskopf W, Woerpel R, eds. Diseases of Cage and Aviary Birds. Baltimore, MD: Williams and Wilkins; 1996:568-571.
10. Cooper JE. Avian microbiology. In: Fudge AM, ed. Laboratory Medicine: Avian and Exotic Pets. Philadelphia, PA: WB Saunders; 2000:90-98.
11. Fudge AM. Avian complete blood count. In: Fudge AM, ed. Laboratory Medicine: Avian and Exotic Pets. Philadelphia, PA: WB Saunders; 2000:90-98.
12. Janesch S. Diagnosis of avian hepatic disease. Semin Avian Exotic Pet Med. 2000;9:126-135.
13. Fudge AM. Avian liver and gastrointestinal testing. In: Fudge AM, ed. Laboratory Medicine: Avion and Exotic Pets. Philadelphia, PA: WB Saunders; 2000:9-18.
14. Rosenthal K. Avian protein disorders. In: Fudge AM, ed. Laboratory Medicine: Avian and Exotic Pets. Philadelphia, PA: WB Saunders; 2000:171-173.
15. Aranaz A, Liebana E, Mateos A, et al. Laboratory diagnosis of avian mycobacteriosis. Semin Avian Exotic Pet Med. 1997;6:9-17.
16. Rae MA, Rosskopf WJ. Mycobacteriosis in passerines. Proc Annu Conf Assoc Avian Vet. 1992: 234-243.
17. Tell LA, Foley J, Needham ML, Walker RL. Diagnosis of avian mycobacteriosis: comparison of culture, acid-fast stains, and polymerase chain reaction for the identification of Mycobacterium avium in experimentally inoculated Japanese quail (Coturnix coturnix japonica). Avian Dis. 2003;47: 444-452.
18. American Thoracic Society, Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med. 1997;156:1-25.
19. Johansen TB, Olsen I, Jensen MR, et al. New probes used for IS1245 and IS1311 restriction fragment length polymorphism of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates of human and animal origin in Norway. BMC Microbiol. 2007;7:14.
20. Mobius P, Lentzsch P, Moser L, Neumann L, et al. Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium subsp. hominissuis isolates from man, pig and cattle. Vet Microbiol. 2006;117:284-291.
21. Bacterial diseases. In: Beers M, Berkow R, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. (on-line version). Merck and Co. 1999:Sec. 13, Ch. 157. Available at: www.merck.com/mrnpe/index.html. Accessed September 12, 2007.
22. Chaisson RE, Bishai WR. MAC and TB infection: management in HIV disease. HIV Clinical Management. Vol. 5. Medscape Inc; 1999. Available at: http://www.medscape.com/medscape/HIV/ClinicalMgmt/CM.v05/public/index-CM.v05. html. Accessed April 2002.
23. Haefner M, Funke-Kissling P, Pfyffer G. Clarithromycin, rifabutin and clofazimine for treatment of disseminated Mycobacterium avium complex disease in AIDS patients. Clin Drug Invest. 1999;17:171-178.
24. Kuijper EJ, de Witte M, Verhagen DW, et al. Mycobacterium genavense infection in two HIV-seropositive patients in Amsterdam. Tijdschriftvoor-Geneeskunde. 1998;142:970-972.
25. Tortoli E, Brunello F, Cagni AE, et al. Mycobacterium genavense in AIDS patients, a report of 24 cases in Italy and review of the literature. Eur J Epidem. 1998;14:219-224.
26. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR. 2002;30 (suppl 1): S29-65.
27. Centers for Disease Control, Division of HIV/ AIDS Prevention. You Can Prevent MAC. Available at http://www.cdc.gov/hiv/pubs/brochure/oi_mac.htm. Accessed August 2004.
28. Preventing Infections From Pets. Online and print bulletins. Available at http://www.cdc.gov/hiv/pubs/brochure/oi_pets.htm. Accessed August 2004.
29. Mangione EJ, Huitt G, Lenaway D, et al. Non-tuberculous mycobacterial disease following hot tub exposure. Emerg Infect Dis. 2001;7:1040-1042.
30. Marras TK, Wallace RJ, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest. 2005;127:664-671.
31. Borody TJ, Leis S, Warren EF, et al. Treatment of severe Crohn's disease using antimycobacterial triple therapy-approaching a cure? Dig Liver Dis. 2002;34:29-38.
32. Shafran I, Kugler L, El-Zaatari FA, et al. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis. 2002;34:22-28.
33. Schoemaker N, Wagenaar J. Diagnosis and treatment of a Mycobacterium tuberculosis infection in a red-lored Amazon (Amazona autumnalis). Proc Annu Conf European Assoc Avian Vet. 1999:24-26.
34. Lennox AM. Antemortem diagnosis and treatment of mycobacteriosis in a budgerigar. Proc Annu Conf Assoc Avian Vet. 1999:425-426.
35. VanDerHeyden N. New strategies in the treatment of avian mycobacteriosis. Semin Avian Exotic Pet Med. 1997;6:25-33.
36. VanDerHeyden N. Update on avian mycobacteriosis. Proc Annu Conf Assoc Avian Vet. 1994:53-61.
37. Benson CA, Williams PL, Currier JS, et al. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. 2003;37: 1234-1243.
38. Taga S, Ogawa K, Nakagawa T, et al. The clinical study on efficacy of clarithromycin, levofloxacin and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection. Kekkaku. 2005;80:1-7.
39. Nannini EC, Keating M, Binstock P, et al. Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. J Infect. 2002;44:201-203.
40. Griffith DE, Brown-Elliot BA, Shepherd S, et al. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2005;172:250-253.